Abstract:BACKGROUND:HeartModel (HM) is a fully automated adaptive quantification software that can quickly quantify left heart volume and left ventricular function. This study used HM to quantify the left ventricular end-diastolic (LVEDV) and end-systolic volumes (LVESV) of patients with dilated cardiomyopathy (DCM), coronary artery heart disease with segmental wall motion abnormality, and hypertrophic cardiomyopathy (HCM) to determine whether there were differences in the feasibility, accuracy, and repeatability of measuring the LVEDV, LVESV, LV ejection fraction (LVEF) and left atrial end-systolic volume (LAESV) and to compare these measurements with those obtained with traditional two-dimensional (2D) and three-dimensional (3D) methods.AIM:To evaluate the application value of HM in quantifying left heart chamber volume and LVEF in clinical patients.METHODS:A total of 150 subjects who underwent 2D and 3D echocardiography were divided into 4 groups: (1) 42 patients with normal heart shape and function (control group, Group A); (2) 35 patients with DCM (Group B); (3) 41 patients with LV remodeling after acute myocardial infarction (Group C); and (4) 32 patients with HCM (Group D). The LVEDV, LVESV, LVEF and LAESV obtained by HM with (HM-RE) and without regional endocardial border editing (HM-NE) were compared with those measured by traditional 2D/3D echocardiographic methods to assess the correlation, consistency, and repeatability of all methods.RESULTS:(1) The parameters measured by HM were significantly different among the groups (P < 0.05 for all). Compared with Groups A, C, and D, Group B had higher LVEDV and LVESV (P < 0.05 for all) and lower LVEF (P < 0.05 for all); (2) HM-NE overestimated LVEDV, LVESV, and LAESV with wide biases and underestimated LVEF with a small bias; contour adjustment reduced the biases and limits of agreement (bias: LVEDV, 28.17 mL, LVESV, 14.92 mL, LAESV, 8.18 mL, LVEF, -0.04%). The correlations between HM-RE and advanced cardiac 3D quantification (3DQA) (r s = 0.91-0.95, P < 0.05 for all) were higher than those between HM-NE (r s = 0.85-0.93, P < 0.05 for all) and the traditional 2D methods. The correlations between HM-RE and 3DQA were good for Groups A, B, and C but remained weak for Group D (LVEDV and LVESV, r s = 0.48-0.54, P < 0.05 for all); and (3) The intraobserver and interobserver variability for the HM-RE measurements were low.CONCLUSION:HM can be used to quantify the LV volume and LVEF in patients with common heart diseases and sufficient image quality. HM with contour editing is highly reproducible and accurate and may be recommended for clinical practice.

Three-Dimensional Modelling of Indexed Papillary Muscle Displacement in Patients Requiring Mitral Valve Surgery Using Four-Dimensional Echocardiography Variables

Three-dimensional Echocardiographic Assessment of Left Ventricular Volume in Different Heart Diseases Using a Fully Automated Quantification Software.

Utility of Real-Time Three-Dimensional Transesophageal Echocardiography in the Intraoperative Assessment of Mltral Valve Repair

Assessment of Left Atrial Strain in Patients Pre-and Post-Mitral Valvuloplasty by Using Two-Dimensional Speckle Tracking Echocardiography

Preliminary Study on the Evaluation of Mitral Annulus Displacement in Normal Fetuses by Automated Cardiac Motion Quantitation

Assessment the Papillary Muscle Function of Functional Mitral Regurgitation Using Speckle Tracking Technology

Hemodynamic testing using three-dimensional printing and computational fluid dynamics preoperatively may provide more information in mitral repair than traditional image dataset

Assessment of Left Ventricular Function in Mitral Regurgitation Patients Using Three-Dimensional Strain and Doppler Parameters

Assessment of papillary muscle function of functional mitral regurgitation patients using two-dimensional speckle tracking technology

Quantitative Assessment of Mitral Valve and Annular Geometry in the Ischemic and Non-Ischemic Mitral Regurgitation by Real-Time Three-Dimensional Transesophageal Echocardiography

Three-dimensional echocardiographic assessment of annular shape changes in the normal and regurgitant mitral valve

Three-dimensional printing of mitral valve models using echocardiographic data improves the knowledge of cardiology fellow physicians in training

Time to Peak Three-Dimensional Strain Significantly Delayed in Asymptomatic Patients with Severe Mitral Regurgitation Although Lvef > 60%

Role of Coaptation Imaging of Mitral Valve on Ischemic Mitral Regurgitation by Real-Time Three-Dimensional Transesophageal Echocardiography

Real-time Three-Dimensional Echocardiography in Diagnosis and Quantitative Assessment of Congenital Mitral Regurgitation

Quantitative assessment of mitral valve apparatus before and after mitral valve surgery by real-time three-dimentional echocardiography

Three dimensional shape and motion analyse of mitral annulus in children with mitral valve regurgitation

Preliminary study of the relationship between the ischemic mitral regurgitation mechanism and geometric structure of the mitral valve in the papillary muscle dysfunction

Evaluation the Alteration of Mitral Valve Structures in Functional Mitral Regurgitation Using Real-Time Three-Dimensional Transesophageal Echocardiography

Papillary muscle repositioning in valve replacement for left ventricular dysfunction: ischemic mitral regurgitation

Study of Degenerative Mitral Regurgitation Using Three‐Dimensional Echocardiography and EchoPAC GE Health Care Software 4D Auto MVQ: Comparison Between Transthoracic and Transesophageal Examination